{
  "patientId": "HL003",
  "demographics": {
    "name": "Samuel Green",
    "dob": "1988-05-10",
    "gender": "Male",
    "address": "789 Forest Ln, Metro City, USA",
    "phone": "555-0303",
    "insurance": "United Healthcare - Policy #UHC-SG-202588",
    "referringPhysician": "Dr. Evelyn Reed (Hematology/Oncology)",
    "emergencyContact": "Jessica Green (Wife) - 555-0304",
    "advanceDirectives": "Full Code. On file, verified 07/18/2025.",
    "supportServices": "Referred to AYA (Adolescent and Young Adult) Oncology Support Group. Nutritional support consult initiated to manage side effects. Long-term survivorship care plan to be created upon completion of therapy.",
    "mobility": "Independent, Ambulatory. ECOG Performance Status 1 (due to B symptoms at diagnosis), improved to 0 post-chemotherapy."
  },
  "diagnosis": {
    "primary": "Classic Hodgkin Lymphoma (CHL), Nodular Sclerosis type",
    "location": "Supradiaphragmatic and Infradiaphragmatic Nodes + Spleen",
    "grade": "N/A",
    "datePathologicDiagnosis": "01/20/2025 (Mediastinoscopy with node biopsy)",
    "tumorSize": "Bulky mediastinal mass measuring 11.2 cm. Mediastinal Mass Ratio (MMR) > 0.33.",
    "pathologicStage": "Ann Arbor Stage IIIB-S. International Prognostic Score (IPS): 2 (Stage IV [due to spleen], Male).",
    "symptomsAtPresentation": "Patient presented with a two-month history of drenching night sweats requiring changes of clothing, an 8% unintentional weight loss, and profound fatigue ('B' symptoms).",
    "pathologyFindings": [
      "Mediastinoscopy with Biopsy (01/20/2025): Nodular Sclerosis Classic Hodgkin Lymphoma. Histologic sections show lymph node architecture effaced by broad collagen bands creating cellular nodules. These nodules contain scattered large, atypical Lacunar-type Reed-Sternberg cells within a mixed inflammatory background. Immunohistochemistry: Reed-Sternberg cells are positive for CD30 and CD15, and negative for CD45 and CD20."
    ],
    "relevantHistory": "No significant past medical history. Works as a high school teacher. Married, no children. No family history of hematologic malignancies.",
    "baselineStatus": "Post-chemotherapy, ECOG 0. B symptoms have fully resolved. Patient reports feeling 'back to normal' and is eager to complete the final phase of his therapy."
  },
  "treatmentPlan": {
    "radOnc": "Dr. Kevin Black",
    "medOnc": "Dr. Evelyn Reed",
    "treatmentSite": "Mediastinum, Supraclavicular, and Para-aortic Nodes",
    "intent": "Curative",
    "modality": "Combined Modality Therapy: Full course chemotherapy followed by consolidative Involved Site Radiation Therapy (ISRT).",
    "totalDose": "30.6 Gy",
    "fractionation": "17 fx",
    "rtRxDetails": "30.6 Gy in 17 fractions (1.8 Gy/fx)",
    "targetVolumeSummary": "The Clinical Target Volume (CTV) is designed to encompass the initial, pre-chemotherapy sites of disease in the mediastinum, bilateral supraclavicular fossae, and upper para-aortic regions, as defined on the staging PET/CT. The PTV is a 0.7 cm expansion on the CTV.",
    "techniqueSummary": "Intensity-Modulated Radiation Therapy (IMRT) delivered using a Deep-Inspiration Breath-Hold (DIBH) technique. IMRT is necessary to deliver a conformal dose to the complex, multi-site target volume while sparing critical organs like the heart, lungs, and kidneys. DIBH is used to increase the distance between the heart and the mediastinal target, further reducing cardiac dose.",
    "priorSystemicChemo": "6 cycles total. Started with ABVD for 2 cycles; interim PET was Deauville 4. Given good clinical response and tolerance, Bleomycin was dropped to reduce lung toxicity risk, and patient completed 4 additional cycles of AVD.",
    "medications": [
      "Magic Mouthwash (Lidocaine/Diphenhydramine/Maalox) - Swish and spit PRN for sore throat.",
      "Loperamide 2mg PO PRN for diarrhea.",
      "Ondansetron 8mg PO PRN for nausea.",
      "Aquaphor for skin in supraclavicular/neck region."
    ],
    "therapistAlerts": [
      "This is a DIBH (Deep-Inspiration Breath-Hold) treatment. Coach patient on breathing and monitor breathing trace daily. Beam is on only during the breath-hold plateau.",
      "Patient is receiving radiation to both chest and abdomen. Monitor closely for esophagitis (sore throat), nausea, and diarrhea.",
      "Daily IGRT with CBCT is critical due to the complex plan and proximity to the heart and lungs.",
      "The treatment field is large and spans multiple isocenters. Verify field matching and couch shifts carefully."
    ]
  },
  "radiationOncologyData": {
    "ctSimulation": {
      "simulationDate": "07/20/2025",
      "setupInstructions": "Supine on a wing board with both arms up, holding T-bar grips. Immobilized in a custom Vac-Lok bag from head to mid-abdomen. Patient was coached on the DIBH maneuver using an active breathing coordinator (ABC) device to ensure reproducibility.",
      "immobilization": "Wing board, Vac-Lok bag (torso).",
      "referenceMarks": "3-point tattoos on chest for initial alignment. DIBH threshold level is the primary positioning verification parameter.",
      "scanner": "Siemens Somatom Confidence 4D CT",
      "sliceThickness": "2.5 mm",
      "contrastUsed": "IV Contrast administered to delineate vessels and nodal anatomy.",
      "ctNotes": "A 4D-CT was first acquired to assess respiratory motion of the mediastinal and abdominal nodes. A planning CT scan was then acquired at the verified DIBH level. The scan was fused with the pre-chemotherapy PET/CT for ISRT target delineation. Patient demonstrated excellent, reproducible breath-holds."
    },
    "dosimetry": {
      "planId": "SGHL003_ISRT_IMRT",
      "planStatus": "Final - Approved by Dr. Kevin Black (07/25/2025)",
      "rx": "30.6 Gy / 17 fx",
      "technique": "IMRT",
      "energy": "6MV",
      "numberOfFieldsOrArcs": 7,
      "tps": "Monaco v5.11",
      "algorithm": "XVMC (Monte Carlo)",
      "hetero": "Yes",
      "norm": "95% of PTV receives 30.6 Gy",
      "constraints": "Heart Mean < 20 Gy (achieved 14.5 Gy); Heart V25 < 10% (achieved 8.2%); Total Lung V20 < 30% (achieved 22.1%); Left Kidney Mean < 12 Gy (achieved 7.8 Gy); Spinal Cord Max < 35 Gy (achieved 28.0 Gy)",
      "igrtProtocol": {
        "frequency": "Daily",
        "type": "Cone Beam CT (CBCT)",
        "alignment": "Initial alignment to bony anatomy (thoracic spine). Final verification based on soft tissue match of the mediastinal target volume. DIBH level confirmed prior to imaging and treatment.",
        "tolerances": "Translational: +/- 3mm"
      },
      "qaChecks": [
        { "date": "2025-07-25", "type": "Initial Chart Check", "by": "Physics Staff (AK)", "result": "Pass" },
        { "date": "2025-07-25", "type": "Patient Specific QA (IMRT)", "by": "Medical Physicist (JL)", "result": "Pass (Gamma 99.3% @ 3%/3mm)" }
      ],
      "fieldDetails": [
        { "fieldName": "Field 1", "fieldSize": "20x22 MLC defined", "gantryAngle": "0", "collimatorAngle": "0", "couchAngle": "0", "energy": "6MV", "monitorUnits": 105, "ssd": "88.5 cm" },
        { "fieldName": "Field 2", "fieldSize": "20x22 MLC defined", "gantryAngle": "51", "collimatorAngle": "25", "couchAngle": "0", "energy": "6MV", "monitorUnits": 120, "ssd": "89.0 cm" },
        { "fieldName": "Field 3", "fieldSize": "20x22 MLC defined", "gantryAngle": "102", "collimatorAngle": "335", "couchAngle": "0", "energy": "6MV", "monitorUnits": 115, "ssd": "92.1 cm" },
        { "fieldName": "Field 4", "fieldSize": "20x22 MLC defined", "gantryAngle": "180", "collimatorAngle": "0", "couchAngle": "0", "energy": "6MV", "monitorUnits": 95, "ssd": "94.0 cm" },
        { "fieldName": "Field 5", "fieldSize": "20x22 MLC defined", "gantryAngle": "204", "collimatorAngle": "25", "couchAngle": "0", "energy": "6MV", "monitorUnits": 115, "ssd": "92.5 cm" },
        { "fieldName": "Field 6", "fieldSize": "20x22 MLC defined", "gantryAngle": "255", "collimatorAngle": "335", "couchAngle": "0", "energy": "6MV", "monitorUnits": 120, "ssd": "89.5 cm" },
        { "fieldName": "Field 7", "fieldSize": "20x22 MLC defined", "gantryAngle": "306", "collimatorAngle": "0", "couchAngle": "0", "energy": "6MV", "monitorUnits": 105, "ssd": "88.0 cm" }
      ]
    },
    "treatmentDelivery": {
      "fractions": [
        {
          "fractionNumber": 1, "totalFractions": 17, "date": "2025-07-28", "machine": "LINAC3", "therapistInitials": "RS, TW",
          "recordedFields": [
        { "fieldName": "Field 1", "fieldSize": "20x22 MLC defined", "gantryAngle": "0", "collimatorAngle": "0", "couchAngle": "0", "energy": "6MV", "monitorUnits": 105, "ssd": "88.5 cm" },
        { "fieldName": "Field 2", "fieldSize": "20x22 MLC defined", "gantryAngle": "51", "collimatorAngle": "25", "couchAngle": "0", "energy": "6MV", "monitorUnits": 120, "ssd": "89.0 cm" },
        { "fieldName": "Field 3", "fieldSize": "20x22 MLC defined", "gantryAngle": "102", "collimatorAngle": "335", "couchAngle": "0", "energy": "6MV", "monitorUnits": 115, "ssd": "92.1 cm" },
        { "fieldName": "Field 4", "fieldSize": "20x22 MLC defined", "gantryAngle": "180", "collimatorAngle": "0", "couchAngle": "0", "energy": "6MV", "monitorUnits": 95, "ssd": "94.0 cm" },
        { "fieldName": "Field 5", "fieldSize": "20x22 MLC defined", "gantryAngle": "204", "collimatorAngle": "25", "couchAngle": "0", "energy": "6MV", "monitorUnits": 115, "ssd": "92.5 cm" },
        { "fieldName": "Field 6", "fieldSize": "20x22 MLC defined", "gantryAngle": "255", "collimatorAngle": "335", "couchAngle": "0", "energy": "6MV", "monitorUnits": 120, "ssd": "89.5 cm" },
        { "fieldName": "Field 7", "fieldSize": "20x22 MLC defined", "gantryAngle": "306", "collimatorAngle": "0", "couchAngle": "0", "energy": "6MV", "monitorUnits": 105, "ssd": "88.0 cm" }
      ],
          "energiesUsed": "6MV", "setupVerification": "Tolerances Met", "immobilizationDevicesChecked": "Wing board, Vac-Lok bag", "setupAdjustments": "None", "organTargetChecks": "CBCT reviewed, DIBH position stable. Heart and lungs well-spared.", "imagingType": "CBCT", "igrtMatchQuality": "Good - No Shifts Required", "shiftsApplied": "None", "igrtApprovedBy": "KB (Physician)",
          "patientTolerance": "Good", "generalSideEffects": "None", "siteSpecificSideEffects": "None", "painAssessment": "0/10", "patientConcerns": "None",
          "instructionsGiven": "Coached on DIBH technique. Reviewed skin care and when to report symptoms.", "billingCodes": "77386, 77387", "dailyNotes": "First treatment delivered. Patient managed DIBH well. CBCT match was excellent. Physician approved initial treatment."
        },
        {
          "fractionNumber": 5, "totalFractions": 17, "date": "2025-08-01", "machine": "LINAC3", "therapistInitials": "RS, TW",
          "recordedFields": [{ "fieldName": "All Fields", "deliveredMu": 780 }],
          "energiesUsed": "6MV", "setupVerification": "Tolerances Met", "immobilizationDevicesChecked": "Wing board, Vac-Lok bag", "setupAdjustments": "None", "organTargetChecks": "CBCT match to mediastinum is good. DIBH consistent.", "imagingType": "CBCT", "igrtMatchQuality": "Good - No Shifts Required", "shiftsApplied": "None", "igrtApprovedBy": "Therapist",
          "patientTolerance": "Good", "generalSideEffects": "Mild fatigue.", "siteSpecificSideEffects": "Early erythema (Grade 1) in supraclavicular region. No esophagitis reported.", "painAssessment": "0/10", "patientConcerns": "None.",
          "instructionsGiven": "Continue skin care. Report any swallowing difficulty.", "billingCodes": "77386, 77387, 77427", "dailyNotes": "OTV today. Patient tolerating RT well. Setup remains consistent and DIBH reproducible."
        },
        {
          "fractionNumber": 10, "totalFractions": 17, "date": "2025-08-08", "machine": "LINAC3", "therapistInitials": "RS, TW",
          "recordedFields": [{ "fieldName": "All Fields", "deliveredMu": 780 }],
          "energiesUsed": "6MV", "setupVerification": "Adjustments Made", "immobilizationDevicesChecked": "Wing board, Vac-Lok bag", "setupAdjustments": "V: 0.1, L: -0.1, S: 0", "organTargetChecks": "CBCT shows stable anatomy. OARs within tolerance.", "imagingType": "CBCT", "igrtMatchQuality": "Good - Shifts Applied", "shiftsApplied": "V: 0.1, L: -0.1, S: 0", "igrtApprovedBy": "Therapist",
          "patientTolerance": "Good", "generalSideEffects": "Moderate fatigue.", "siteSpecificSideEffects": "Mild sore throat (Grade 1 esophagitis). Skin erythema (Grade 1) is stable. Mild diarrhea (2-3 loose stools/day).", "painAssessment": "1/10 (throat)", "patientConcerns": "Sore throat and some loose stools.",
          "instructionsGiven": "Recommended Magic Mouthwash for throat. Advised low-residue diet and Loperamide for diarrhea.", "billingCodes": "77386, 77387, 77427", "dailyNotes": "OTV today. Patient experiencing expected side effects from the large treatment volume. Supportive care measures initiated. Patient remains in good spirits."
        },
        {
          "fractionNumber": 17, "totalFractions": 17, "date": "2025-08-19", "machine": "LINAC3", "therapistInitials": "RS, TW",
          "recordedFields": [{ "fieldName": "All Fields", "deliveredMu": 780 }],
          "energiesUsed": "6MV", "setupVerification": "Tolerances Met", "immobilizationDevicesChecked": "Wing board, Vac-Lok bag", "setupAdjustments": "None", "organTargetChecks": "Final CBCT reviewed. Excellent final alignment.", "imagingType": "CBCT", "igrtMatchQuality": "Excellent", "shiftsApplied": "None", "igrtApprovedBy": "KB (Physician)",
          "patientTolerance": "Good", "generalSideEffects": "Moderate fatigue.", "siteSpecificSideEffects": "Sore throat is resolving. Diarrhea controlled with Loperamide. Skin is moderately red but intact.", "painAssessment": "0/10", "patientConcerns": "Relieved treatment is complete. Asked when side effects will resolve.",
          "instructionsGiven": "End-of-treatment instructions provided. Side effects will resolve over the next few weeks. Reminded of importance of long-term follow-up for cardiac and thyroid monitoring.", "billingCodes": "77386, 77387", "dailyNotes": "Final treatment delivered. Patient tolerated the full course well. Confirmed follow-up appointments with Med Onc and Rad Onc."
        }
      ]
    }
  },
  "imagingAndReports": [
    { "date": "01/20/2025", "type": "Surgical Pathology Report", "summary": "Nodular Sclerosis Classic Hodgkin Lymphoma from Mediastinal Biopsy.", "reportDetails": { "accessionNumber": "S-25-8899", "specimenSource": "Mediastinoscopy with biopsy of prevascular lymph node.", "diagnosis": "Nodular Sclerosis Classic Hodgkin Lymphoma (CHL)", "microscopicDescription": "The lymph node architecture is effaced by nodules of mixed inflammatory cells, separated by dense collagen bands. Within the nodules, characteristic Lacunar-type Reed-Sternberg cells are identified.", "immunohistochemistry": "The atypical cells are positive for CD30 and CD15, and negative for CD45 and CD20, confirming the diagnosis of CHL." } },
    { "date": "01/18/2025", "type": "FDG-PET/CT (Staging)", "summary": "Intensely FDG-avid bulky mediastinal mass (MMR 0.4). Avid SCV and para-aortic nodes. Diffuse splenic uptake. Stage IIIB-S.", "reportDetails": { "accessionNumber": "PET-25-1801", "protocol": "Whole Body FDG-PET/CT", "findings": "Intensely hypermetabolic activity (SUVmax 18.5) within the bulky mediastinal mass. The mediastinal mass to thoracic diameter ratio (MMR) is 0.4. Avid lymphadenopathy is confirmed in the supraclavicular and para-aortic regions. There is diffuse, heterogeneous uptake throughout the spleen, consistent with splenic involvement.", "impression": "Deauville Score 5. Findings confirm Stage IIIB-S Hodgkin Lymphoma." } },
    { "date": "03/25/2025", "type": "FDG-PET/CT (Interim - post C2)", "summary": "Significant response, but residual uptake > liver (Deauville 4).", "reportDetails": { "accessionNumber": "PET-25-3251", "protocol": "Whole Body FDG-PET/CT", "comparison": "PET/CT from 01/18/2025", "findings": "Significant interval decrease in the size and avidity of the mediastinal mass and other nodal sites. However, there is residual hypermetabolic activity in the mediastinum with an SUVmax of 8.5, which remains greater than liver uptake.", "impression": "Deauville Score 4. The response indicates tumor sensitivity to chemotherapy, but is not a complete metabolic response. Plan is to continue with AVD chemotherapy as per protocol." } },
    { "date": "07/10/2025", "type": "FDG-PET/CT (End of Chemo)", "summary": "Further response. Residual mediastinal tissue with low-grade uptake <= liver (Deauville 3).", "reportDetails": { "accessionNumber": "PET-25-7101", "protocol": "Whole Body FDG-PET/CT", "comparison": "PET/CT from 03/25/2025", "findings": "Further interval decrease in size and metabolic activity of all disease sites. There is faint residual uptake in the mediastinum with an SUVmax of 2.5, which is now less than or equal to background liver uptake.", "impression": "Deauville Score 3. A good metabolic response, considered a near complete response. Findings support proceeding with consolidative ISRT." } }
  ],
  "labResults": [
    { "date": "01/20/2025", "test": "CBC - Hgb", "value": "10.2", "units": "g/dL", "notes": "Anemia (Hgb < 10.5 g/dL) is an adverse risk factor for advanced stage disease, but does not add to IPS score in this case." },
    { "date": "01/20/2025", "test": "CMP - Albumin", "value": "3.8", "units": "g/dL", "notes": "Low normal. Albumin < 4.0 g/dL is an adverse risk factor." },
    { "date": "07/15/2025", "test": "CBC (Pre-RT)", "value": "WBC 4.8, Hgb 12.8, Plt 220k", "notes": "Counts have recovered well post-chemotherapy. Cleared for RT." },
    { "date": "07/15/2025", "test": "TSH (Pre-RT)", "value": "2.1", "units": "mIU/L", "notes": "Baseline thyroid function prior to neck/chest irradiation." }
  ],
  "progressNotes": [
    { "date": "01/22/2025", "author": "Dr. Evelyn Reed (Med Onc)", "type": "Initial Consult", "summary": "36yo Male presents with classic B symptoms. Biopsy confirms NS-CHL. Staging PET/CT reveals Stage IIIB-S disease with a bulky mediastinum. International Prognostic Score (IPS) is 2. This is advanced-stage disease requiring a full course of chemotherapy. Plan is to start with 2 cycles of ABVD, then interim PET to guide subsequent therapy." },
    { "date": "03/26/2025", "author": "Dr. Evelyn Reed (Med Onc)", "type": "Post-Cycle 2 Visit", "summary": "Interim PET after 2 cycles of ABVD shows a Deauville 4 response. While not a complete metabolic response, this is still a significant reduction in disease burden. Given good clinical tolerance and significant improvement, the decision is to continue chemotherapy without escalation. We will drop the Bleomycin to reduce the risk of pulmonary toxicity in preparation for radiation, and proceed with 4 additional cycles of AVD. Plan remains for consolidative ISRT after completion of all chemotherapy." },
    { "date": "07/12/2025", "author": "Dr. Evelyn Reed (Med Onc)", "type": "End of Chemotherapy Visit", "summary": "Samuel has completed 6 total cycles of chemotherapy. He tolerated the treatment relatively well. End-of-treatment PET shows a very good response, now a Deauville 3. This is an adequate response to proceed with consolidation. I have placed a referral to Dr. Black in Radiation Oncology for consolidative ISRT to the initial sites of disease." },
    { "date": "07/18/2025", "author": "Dr. Kevin Black (Rad Onc)", "type": "Initial Consult", "summary": "Patient is a 37 y/o male with Stage IIIB-S CHL, s/p 6 cycles of chemo with a final Deauville 3 response. I have reviewed his extensive imaging. The plan is for consolidative ISRT to the mediastinum, supraclavicular, and para-aortic regions to a total dose of 30.6 Gy in 17 fractions. Given the complex target volume spanning the diaphragm, we will use IMRT with a DIBH technique to best spare his heart and lungs. We discussed the procedure, rationale, and potential side effects (fatigue, esophagitis, skin reaction, nausea/diarrhea). Patient understands and agrees to proceed. CT simulation scheduled." }
  ],
  "patientEducation": {
    "goalsDiscussed": "To deliver consolidation radiation after a full course of chemotherapy. This is a critical component of curative therapy for advanced-stage Hodgkin Lymphoma, designed to treat areas of initial disease (especially bulky sites) to reduce the risk of relapse.",
    "sideEffectsReviewed": "Acute: Fatigue is the most common side effect. Because the field covers the chest and abdomen, he may experience a sore throat (esophagitis), nausea, and/or diarrhea. Mild skin redness in the neck and chest is also possible. Late: Explained the long-term risks, which modern IMRT and DIBH techniques help to minimize. These include hypothyroidism, heart disease, lung inflammation (pneumonitis), and a small risk of secondary cancers decades later.",
    "safetyConsiderations": "Using the DIBH device correctly is key to protecting the heart. Report any severe sore throat, difficulty swallowing, chest pain, or shortness of breath immediately. Follow dietary guidance to manage GI side effects. Maintain good hydration.",
    "patientResponsibilities": "Attend all daily RT appointments. Practice and perform the DIBH maneuver as coached. Report all side effects to the team.",
    "medicationCompliance": "Use prescribed supportive medications (anti-nausea, anti-diarrheal, mouthwash) as needed to manage symptoms."
  },
  "scheduling": [
    { "date": "01/20/2025", "type": "Mediastinoscopy/Biopsy", "location": "Operating Room", "status": "Completed" },
    { "date": "Jan 2025 - Jul 2025", "type": "Chemotherapy (ABVD/AVD x 6)", "location": "Infusion Center", "status": "Completed" },
    { "date": "03/25/2025", "type": "Interim PET/CT Scan", "location": "Radiology Department", "status": "Completed" },
    { "date": "07/10/2025", "type": "End of Chemo PET/CT Scan", "location": "Radiology Department", "status": "Completed" },
    { "date": "07/18/2025", "type": "Radiation Oncology Consult", "location": "Rad Onc Clinic", "status": "Completed" },
    { "date": "07/20/2025", "type": "CT Simulation (DIBH)", "location": "Rad Onc Sim Suite", "status": "Completed" },
    { "date": "07/28/2025", "type": "RT Start (Fx 1/17)", "location": "LINAC 3", "status": "Completed" },
    { "date": "08/19/2025", "type": "RT End (Fx 17/17)", "location": "LINAC 3", "status": "Completed" },
    { "date": "09/19/2025", "type": "1-Month Post-RT Follow-up", "location": "Rad Onc Clinic", "status": "Scheduled" },
    { "date": "11/19/2025", "type": "3-Month Post-Treatment PET/CT", "location": "Radiology Department", "status": "Scheduled" }
  ],
  "cptCharges": [
    { "code": "77290", "description": "Simulation, Complex (IMRT)", "frequency": "Once" },
    { "code": "77334", "description": "Treatment device, Complex (Wing board/Vac-Lok)", "frequency": "Once" },
    { "code": "77293", "description": "Respiratory motion management simulation (DIBH)", "frequency": "Once" },
    { "code": "77301", "description": "IMRT planning, complex", "frequency": "Once" },
    { "code": "77386", "description": "IMRT delivery, complex", "frequency": "17" },
    { "code": "77387", "description": "Image Guided RT (IGRT - Daily CBCT)", "frequency": "17" },
    { "code": "77427", "description": "Radiation treatment management, 5 treatments", "frequency": "4" }
  ],
  "diagnosisSearch": "Hodgkin Lymphoma, Advanced Stage, Bulky Disease, IMRT, DIBH"
}
